Surgery Partners (NASDAQ:SGRY) Posts Q3 Sales In Line With Estimates But Stock Drops 13.5% [Yahoo! Finance]
Surgery Partners, Inc. (SGRY)
Last surgery partners, inc. earnings: 3/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.surgerypartners.com/investor-overview
Company Research
Source: Yahoo! Finance
On the other hand, the company's full-year revenue guidance of $3.29 billion at the midpoint came in 2% below analysts' estimates. Its non-GAAP profit of $0.13 per share was 19% below analysts' consensus estimates. Is now the time to buy Surgery Partners? Find out in our full research report Surgery Partners (SGRY) Q3 CY2025 Highlights: Revenue: $821.5 million vs analyst estimates of $821.8 million (6.6% year-on-year growth, in line) Adjusted EPS: $0.13 vs analyst expectations of $0.16 (19% miss) Adjusted EBITDA: $136.4 million vs analyst estimates of $136.2 million (16.6% margin, in line) The company dropped its revenue guidance for the full year to $3.29 billion at the midpoint from $3.38 billion, a 2.6% decrease EBITDA guidance for the full year is $537.5 million at the midpoint, below analyst estimates of $556.1 million Operating Margin: 12.9%, up from 7.9% in the same quarter last year Free Cash Flow Margin: 7.8%, up from 5.8% in the same quarter last year Sal
Show less
Read more
Impact Snapshot
Event Time:
SGRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGRY alerts
High impacting Surgery Partners, Inc. news events
Weekly update
A roundup of the hottest topics
SGRY
News
- Surgery Partners (NASDAQ:SGRY) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Assessing Surgery Partners (SGRY) Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound [Yahoo! Finance]Yahoo! Finance
- Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at JPMorgan Chase & Co. from $27.00 to $20.00. They now have a "neutral" rating on the stock.MarketBeat
- Surgery Partners (NASDAQ:SGRY) was given a new $18.00 price target on by analysts at Barclays PLC.MarketBeat
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRYPR Newswire
SGRY
Earnings
- 11/10/25 - Beat
SGRY
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- SGRY's page on the SEC website